KRYS · short Krystal Biotech INC
Krystal Biotech is a profitable commercial-stage biotech with an $8.7 billion enterprise value and one FDA-approved topical gene therapy,…
NASDAQ
Krystal Biotech, Inc.
KRYS
1 article
$11B Market cap · 2026-09-01
KRYS · short 